Press & events

What's happening?

Stay updated on our latest news and events.

Displaying 11 - 20 of 406

Press

Recipharm signs manufacturing agreement with Enzymatica

2021.01.13 Read more

Press

Recipharm has convened a bondholder meeting to correct the terms and conditions of its convertible bonds and announces date for a preliminary 2020 year-end report

2021.01.11 Read more

Press

Announcement of consent solicitation by Recipharm AB (publ) in respect of its SEK 1,000,000,000 Senior Unsecured Convertible Bonds due 2021 (ISIN: XS1496895753)

2021.01.11 Read more

Press

Recipharm and Moderna finalize agreement for aseptic drug product manufacturing and fill-finish for supply to countries outside the U.S.

2020.12.30 Read more

Press

Comment from Recipharm’s board of directors regarding the public offer from Roar BidCo and correction of error in convertible bond terms

2020.12.14 Read more

Press

Recipharm invests USD 2.5 million in clinical GMP capacity for active pharmaceutical ingredients

2020.12.09 Read more

Press

Recipharm announces signature of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273)

2020.11.24 Read more

Press

Recipharm and Medspray establish joint venture to exploit novel softmist technology for pharmaceutical applications

2020.11.17 Read more

Press

Recipharm invests in its pMDI valves production capacity

2020.11.10 Read more

Press

Recipharm AB publishes its interim report for the third quarter 2020

2020.11.05 Read more